Carmustine induces platelet apoptosis

References

• La Rocca RV, Mehdorn HM. Localized BCNU chemotherapy and the multimodal management of malignant glioma. Curr Med Res Opin 2009;25:149–160
   PubMed Web of Science ®Google Scholar
• Smith BD, Wilson LD. Cutaneous lymphoma. Curr Probl Cancer 2008;32:43–87
   PubMedGoogle Scholar
• Wondergem MJ, Zijlstra JM, de Rooij M, Visser OJ, Huijgens PC, Zweegman S. Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation. Br J Haematol 2012;157:395–397
   PubMed Web of Science ®Google Scholar
• Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333–343
   PubMed Web of Science ®Google Scholar
• Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003;5:79–88
   PubMed Web of Science ®Google Scholar
• Micetich KC, Futscher B, Koch D, Fisher RI, Erickson LC. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer. J Natl Cancer Inst 1992;84:256–260
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma. Int J Radiat Oncol Biol Phys 1998;42:969–975
   PubMed Web of Science ®Google Scholar
• Barrié M, Couprie C, Dufour H, Figarella-Branger D, Muracciole X, Hoang-Xuan K, Braguer D, Martin PM, Peragut JC, Grisoli F, Chinot O. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme. Ann Oncol 2005;16:1177–1184
   PubMed Web of Science ®Google Scholar
• Reithmeier T, Graf E, Piroth T, Trippel M, Pinsker MO, Nikkhah G. BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. BMC Cancer 2010;10:30
   PubMed Web of Science ®Google Scholar
• Elting LS, Rubenstein EB, Martin CG, Kurtin D, Rodriguez S, Laiho E, Kanesan K, Cantor SB, Benjamin RS. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 2001;19:1137–1146
   PubMed Web of Science ®Google Scholar
• Lassen U, Kristjansen PE, Wagner A, Kosteljanetz M, Poulsen HS. Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study. J Neurooncol 1999;43:161–166
   PubMedGoogle Scholar
• Thamilselvan V, Menon M, Thamilselvan S. Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells. Cancer Manag Res 2012;4:383–395
   PubMedGoogle Scholar
• Van Meter TE, Broaddus WC, Cash D, Fillmore H. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas. Cancer 2006;107:2446–2454
   PubMedGoogle Scholar
• Papait R, Magrassi L, Rigamonti D, Cattaneo E. Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochem Biophys Res Commun 2009;379:434–439
   PubMedGoogle Scholar
• Helal GK, Aleisa AM, Helal OK, Al-Rejaie SS, Al-Yahya AA, Al-Majed AA, Al-Shabanah OA. Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats. Oxid Med Cell Longev 2009;2:26–35
   PubMedGoogle Scholar
• An JM, Kim SS, Rhie JH, Shin DM, Seo SR, Seo JT. Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species. Toxicol In Vitro 2011;25:1359–1365
   PubMedGoogle Scholar
• Lytle RA, Jiang Z, Zheng X, Rich KM. BCNU down-regulates anti-apoptotic proteins Bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells. J Neurooncol 2004;68:233–241
   PubMedGoogle Scholar
• Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006;4:2656–2663
   PubMed Web of Science ®Google Scholar
• Wang Z, Li S, Shi Q, Yan R, Liu G, Dai K. Calmodulin antagonists induce platelet apoptosis. Thromb Res 2010;125:340–350
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhao L, Liu J, Du J, Wang Z, Ruan C, Dai K. Cisplatin induces platelet apoptosis through the ERK signaling pathway. Thromb Res 2012;130:81–91
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang W, Chen M, Zhang J, Zhang M, Dai K. Aspirin Induces platelet apoptosis. Platelets 2013;24:637–642
   PubMed Web of Science ®Google Scholar
• Li S, Wang Z, Liao Y, Zhang W, Shi Q, Yan R, Ruan C, Dai K. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost 2010;8:341–350
   PubMed Web of Science ®Google Scholar
• Dai K, Bodnar R, Berndt MC, Du X. A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications. Blood 2005;106:1975–1981
   PubMedGoogle Scholar
• Chen K, Zhang Q, Wang J, Liu F, Mi M, Xu H, Chen F, Zeng K. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res 2009;1279:131–138
   PubMed Web of Science ®Google Scholar
• Lin KH, Chang HC, Lu WJ, Jayakumar T, Chou HC, Fong TH, Hsiao G, Sheu JR. Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents. Platelets 2009;20:575–581
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mykhaylov S, Mis L, Lyubimov EV, Garvey B, Freedman J. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun 2004;320:303–310
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309–1312
   PubMed Web of Science ®Google Scholar
• Karolak L, Chandra A, Khan W, Marks B, Petros WP, Peters WP, Greenberg CS, Hannun YA. High-dose chemotherapy-induced platelet defect: Inhibition of platelet signal transduction pathways. Mol Pharmacol 1993;43:37–44
   PubMedGoogle Scholar
• El-Sayed el-SM, Abdel-Aziz AA, Saleh S, Saad AS. The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in rats. Food Chem Toxicol 2011;49:1965–1969
   PubMedGoogle Scholar
• Chen ZP, Wang G, Huang Q, Sun ZF, Zhou LY, Wang AD, Panasci LC. Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model. J Neurooncol 1999;44:7–14
   PubMed Web of Science ®Google Scholar